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Follicular and serum levels of vitamin D in women with 
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fertilization outcome: an observational pilot study
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A b s t r a c t
Introduction: Follicular and serum vitamin D are considered potential mark-
ers of the oocyte and embryos’ quality and predictors of in vitro fertilization 
(IVF) outcomes. 
Methods: This retrospective cross-sectional study correlated vitamin  D in 
sera and follicular fluid of women with unexplained infertility mutually and 
with IVF outcomes. ELISA was used for measuring vitamin D.
Results: The results show positive correlation only between follicular and se-
rum levels of vitamin D (Rho = 0.615, p = 0.025), and between follicular lev-
els of vitamin D and the percentage of embryo fragmentation (Rho = 0.544; 
p = 0.036). 
Conclusions: The results suggest that serum and follicular fluid vitamin D 
measurements could be complementary tools to the routine assessment of 
embryos. 
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The presence of vitamin  D receptors in the human ovaries, uterus, 
and placenta has suggested its reproductive physiology role [1]. Infertile 
women with polycystic ovary syndrome (PCOS) have lower serum vita-
min D than fertile women [2]. Women with endometriosis were found 
to have unbalanced, both higher [3] and lower [4], levels of vitamin D. 
In vitro fertilization (IVF) represents a valuable model for evaluating the 
influence of vitamin D on human fertility. It enables assessment of each 
stage of the reproductive process, from sperm function, through follicu-
logenesis, to embryo implantation [5]. Recently, follicular vitamin D lev-
els are being considered as potential markers of the oocyte and embryo 
quality and predictors of IVF outcome [6].
Consequently, combining serum and follicular vitamin D analysis with 
embryo morphological assessment could provide a more accurate and 
sensitive method of determining embryonic developmental capability. 
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Vitamin D has an effect on the outcome of con-
trolled ovarian stimulation (COS) in women under-
going IVF [7, 8]. However, the correlation between 
serum and follicular fluid (FF) levels of vitamin D 
exclusively in women with unexplained infertility, 
identified in 10–30% of couples undergoing IVF, 
has not been investigated yet. Unexplained infer-
tility is defined as the absence of conception de-
spite 12 months of unprotected intercourse, not 
explained by anovulation, poor sperm quality, tub-
al pathology, or any known cause of infertility [9].
The main objective of this study was to deter-
mine correlations between serum and FF levels of 
vitamin  D in women with unexplained infertility 
and to assess the relationship between serum and 
FF levels of vitamin D on the day of oocyte retriev-
al and some important IVF outcomes. 
Methods. In this retrospective cross-sectional 
study, vitamin D levels in sera and FF of women 
undergoing IVF at the IVF Department of Clinic for 
Gynaecology and Obstetrics “Narodni front”, Bel-
grade, from September 2012 to January 2014 were 
measured and correlated with the study outcomes 
(e.g. the number of perifollicular follicles, the num-
ber of retrieved oocytes, the number of Metaphase 
II oocytes (MII), the percentage of embryo frag-
mentation, the two-pronuclear zygote (2pn), the 
number of embryos, and the implantation rate). 
The Institutional Review Board of the Clinic for 
Gynaecology and Obstetrics “Narodni front” ap-
proved the study (Decision#05006-2019-21822). 
Informed consent was provided by all participants.
Inclusion study criteria comprised unexplained 
infertility, age up to 38 years, body mass index 
(BMI) up to 30 kg/m2, first fresh autologous IVF 
cycle, and primary infertility. Exclusion criteria 
were known causes of male and female infertili-
ty (such as male infertility factor, endometriosis, 
and PCOS), factors related to female genitalia that 
could cause fertility problems (such as myomas 
distorting endometrial cavity, endometrial polyps, 
uterine anomalies), previous vitamin  D supple-
mentation, the use of drugs that affect the metab-
olism of vitamin D, earlier surgeries on the ovary 
and fallopian tubes, hypothalamic amenorrhoea, 
galactorrhoea, and systemic and infective diseas-
es. Unexplained infertility was diagnosed after 
the absence of conception despite 12 months of 
unprotected intercourse, not explained by anovu-
lation, poor sperm quality, tubal pathology, or any 
known cause of infertility such as thrombophilia, 
insulin resistance, thyroid disorders, etc. [9].
Practices and protocols of IVF Clinic for Gy-
naecology and Obstetrics “Narodni front” re-
garding COS, oocyte retrieval, and embryo trans-
fer (ET) have been previously described [10–12]. 
Micronized progesterone 600 mg/day and 250 
mg hydroxyprogesterone caproate were used 
for luteal support every fifth day. Serum b-hCG 
> 50 mIU/ml on the 16th day after retrieval was 
considered as biochemical pregnancy. A  gesta-
tional sac or foetal pole visualized on an ultra-
sound at the 7th week of gestation was deemed 
as clinical pregnancy. All pregnancy rates were 
calculated per ET.
Blood was collected from all participants imme-
diately before COS initiation. FF and blood sam-
ples were collected after COS on the day of oocyte 
retrieval. Serum oestradiol (E2) levels were mea-
sured by chemiluminescence assay using an au-
tomated analyser (Roche Diagnostics GmbH, Ger-
many). Serum and FF vitamin D were measured by 
ELISA using 25-OH vitamin D-Euroimun from the 
Perkin Elmer company, Medizinische Labordiag-
nostika AG (Germany), using Multilabel Counter 
Perkin Elmer, Singapore. 
The analysed characteristics of participants 
were as follows: BMI, infertility duration, baseline 
serum E2, antral follicle count (AFC). The analysed 
parameters of COS were as follows: perifollicular 
follicles, retrieved oocytes, and MII number, per-
centage of embryo fragmentation, 2pn, embryos 
number, and implantation rate. Perifollicular folli-
cle identified by ultrasound at trigger day is de-
fined as follicle with diameter > 16 mm. MII is an 
oocyte at metaphase II showing a polar body at 
the top. The percentage of embryo fragmentation 
presents a percentage of the perivitelline space’s 
volume and/or cleavage cavity occupied by anu-
cleate cytoplasmic fragments. A 2pn is defined as 
a zygote with the appearance of two pronuclei ob-
served 18 h after insemination/ICSI. The implan-
tation rate (IR) is calculated as per equation: IR = 
n-gestational sacs/n-transferred embryos, where 
n-gestational sacs is the number of gestational 
sacs observed at vaginal ultrasound 3–5 weeks 
after transfer, and n-transferred embryos is the 
number of transferred embryos [13].
Statistical analysis. Descriptive statistical meth-
ods are used to present data as mean ± standard 
deviation (SD), median, and percentiles. Student’s 
t-test and Spearman’s correlation analysis were 
used as analytical, statistical methods. A p-value 
< 0.05 was considered significant. Statistical Pack-
age for the Social Sciences 12.0 (SPSS Inc., Chica-
go) was used for all statistical calculations.
Results. During the study period, 382 women 
underwent IVF procedures, of whom 107 were 
with unexplained infertility (the prevalence of un-
explained infertility was 28.01%). The application 
of study inclusion/exclusion criteria left 16 pa-
tients to analyse further serum and FF vitamin D 
levels and parameters of IVF outcome. The mean 
age of the study cohort patients was 34.0 ±2.3 
years, with a BMI of 22.11 ±1.62 kg/m2. The me-
dian duration of infertility was 4.6 ±3.5 years, and 
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the AFC was 8.07 ±5.1, while the baseline serum E2 
and AMH were 93.13 ±53.02 pmol/l and 2.51 
±1.93 ng/ml, respectively. Characteristics of IVF 
treatment/outcome and the serum and FF levels 
of vitamin D are presented in Table I. When com-
pared, the vitamin D concentrations in serum and 
in FF showed no statistically significant differenc-
es (mean difference 4.6692, T 0.418, p = 0.684). 
A significant positive correlation was evident be-
tween serum and FF vitamin D levels according to 
Rho = 0.615, p = 0.025. The biochemical pregnan-
cy rate was 56.25%, while the clinical pregnancy 
rate was 50%. All achieved pregnancies in the 
study population were singleton, and the live birth 
rate was 37.5%. Table II summarizes the results of 
the correlation analysis used to examine associ-
ations of serum and FF vitamin D levels with the 
study outcomes. A  positive correlation between 
FF vitamin D levels and the percentage of embryo 
fragmentation (Rho = 0.544; p = 0.036) was deter-
mined. Other tested parameters of IVF outcome 
such as number of retrieved oocytes, number of 
perifollicular follicles, MII oocytes, 2pn, number 
of embryos, and implantation rate did not attain 
statistical significance with either serum or FF vi-
tamin D levels. 
Discussion. Vitamin D receptors in the human 
ovaries, uterus, and placenta have a suggested re-
productive physiology role [1]. Recently, follicular 
vitamin D levels have been considered as poten-
tial markers of the oocyte and embryo quality and 
predictors of IVF outcome [6]. Combining serum 
and follicular vitamin D analysis with embryo mor-
phological assessment could provide a more accu-
rate and sensitive method of determining embry-
onic developmental capability.
In the present study in women with unex-
plained infertility, we observed a significant pos-
itive correlation between serum and FF vitamin D 
levels.  This finding is consistent with previous 
studies [6, 14–16], showing that the serum and 
FF vitamin D levels significantly correlate. We did 
not observe significant differences between se-
rum and FF vitamin  D concentrations. Contrary 
to our results, other studies show a higher vita-
min D concentration in the FF than in serum [7, 
14, 15]. The reason might be that the association 
between vitamin  D and COS and IVF outcomes 
differs according to infertility diagnosis [7] in an 
overall population of infertile women undergoing 
IVF. Consequently, this issue has been evaluated 
in populations encompassing women with PCOS 
and endometriosis [2–4], known as women with 
altered vitamin D levels compared to the general 
female population. Also, the foundations of unex-
plained infertility evaluated in the current study 
Table I. Characteristics of IVF treatment and out-
come and levels of vitamin D in serum and follic-
ular fluid 
Parameter Mean ± SD/median  
(25–75th percentile)
COS duration [days] 10.00 ±1.48
Maximal value of E2 [pmol/ml] 7328.31 ±2170.9
E2 on triggering day [pmol/ml] 7087.13 ±2342.82
No. of perifollicular follicles 8.75 ±3.75
Retrieved oocytes 7.87 ±2.60
MII oocytes 5.25 ±2.24
2pn 3.00 (2.50–5.50)
Fragmentation rate 79.16 (64.29–100)
Total No of embryos 3.0 (2.5–5.5)
No. of grade 1 embryos 0.5 (0–2.0)
No. of grade 2 embryos 1.5 (0.5–3.0)
No. of grade 3 embryos 0.5 (0–1.0)
Implantation rate 16.67 (0–41.67)
Serum vitamin D [nmol/l] 69.8 (35.1–82.9)
Follicular fluid vitamin D [nmol/l] 51.2 (31.4–66.8)
Results are presented as mean ± SD for normally distributed 
variables and median (25–75th percentile) for non-normally 
distributed variables. IVF – in vitro fertilization, COS – controlled 
ovarian stimulation, E
2
 – oestradiol, MII – metaphase II, SD – 
standard deviation.
Table II. Correlations between serum and follicular levels of vitamin D and the study outcomes
Spearman’s rho Serum vitamin D P-value Follicular vitamin D P-value
Serum vitamin D Rho NA / 0.615 0.025
Follicular vitamin D Rho 0.615 0.025 NA /
No. of retrieved oocytes Rho –0.291 0.312 0.100 0.723
% of fragmentation Rho 0.446 0.110 0.544 0.036
No. of perifollicular follicles Rho 0.268 0.354 0.217 0.437
MII oocytes Rho –0.395 0.162 –0.065 0.817
2pn Rho –0.174 0.553 0.077 0.786
No. of embryos Rho –0.174 0.553 0.077 0.553
Implantation rate Rho 0.494 0.072 0.082 0.772
MII – metaphase II; 2pn – two-pronuclear zygote.
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might encompass elusive imbalances in a wide ar-
ray, many of which may not be susceptible to the 
effects of serum and FF vitamin D levels. 
With the regularity of blastomeres, the em-
bryo fragmentation percentage is the most im-
portant in the embryo quality’s morphological 
assessment. It reflects not only the quality but 
also the viability of the embryo. The present study 
analysed the correlation between serum and FF 
vitamin  D levels with the percentage of embryo 
fragmentation. The results obtained in this study 
for correlation between FF vitamin D and the per-
centage of embryo fragmentation are similar to 
the results reported in the other studies [6, 16]. 
This study shows a significant positive correlation 
between FF vitamin D and the percentage of em-
bryo fragmentation. This result could mean that 
although vitamin D at physiological levels plays an 
important role in endometrial receptivity, its an-
ti-oestrogenic effect is detrimental to oocyte de-
velopment and embryo quality [17]. However, this 
issue should be considered differently in various 
infertility causes and in different metabolic and 
hormonal backgrounds. 
In conclucion, the findings from this pilot study 
confirmed the feasibility of serum and FF vita-
min D measurements in women with unexplained 
infertility undergoing IVF. Some of the results of 
this study suggest that combining serum and FF 
vitamin D measurements with other assessment 
tools (such as routine morphological assessment 
of the embryo) could allow a more precise meth-
od for predicting embryonic developmental com-
petence and different important IVF outcomes. 
Although many factors can cause infertility, these 
findings are significant because vitamin  D defi-
ciency may explain some unexplained infertility 
cases or contribute to the other causes of infer-
tility. 
The limitations of the current study need to be 
reported. It is an observational pilot study with 
a small number of patients, and firm inclusion cri-
teria were applied. Additionally, it has a retrospec-
tive design with different infertility assessments 
or different IVF approaches to infertile patients. 
Although vitamin D seems to benefit the over-
all population of infertile women or those with 
PCOS or endometriosis, this influence has not yet 
been proven for women with unexplained infertil-
ity. Accordingly, it is crucial to test if facts recog-
nized for the universal population are appropriate 
for each type of patient or infertility cause. Future 
prospective studies might be relevant, to advise 
whether it is reasonable to inform infertile wom-
en with unexplained infertility undergoing IVF to 
evaluate serum vitamin D status before COS initi-
ation. Longitudinal studies with larger numbers of 
participants are necessary to confirm our results, 
i.e. that serum and follicular fluid vitamin D mea-
surements could be complementary tools to the 
routine assessment of embryos.
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